Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generation of Triptorelin Positive Samples for Anti-doping
NCT04189900Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Apr 2019
- Primary completion
- May 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of triptorelin in prostate cancer (PCa), sponsored by Parc de Salut Mar. Primary endpoint: Urine concentration of triptorelin. Started Apr 2019; status: completed.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04189900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189900.